What the research found

The National Institute on Aging convened a workshop in late 2025 bringing together researchers across multiple NIH divisions and the Veterans Health Administration to examine how biological sex shapes health trajectories and disease risk throughout life. Rather than presenting new experimental data, the workshop synthesized existing evidence and identified gaps in how sex differences are studied across different organ systems and age groups.

The discussions centred on understanding mechanisms—the biological pathways that explain why health outcomes diverge between sexes, rather than just documenting that they do. Participants explored how sex-linked factors operate differently at various life stages, and highlighted emerging technologies and research approaches that could deepen this understanding.

Why it matters for you

Sex-based differences in how the body responds to training, supplementation, and hormonal interventions are real, but often underexplored in the research literature and in optimization protocols. If you're tracking TRT, peptides, or performance metrics, the underlying biology—hormone receptor sensitivity, mitochondrial function, metabolic capacity, immune regulation—likely differs meaningfully from someone of another sex, even at matched ages or biomarker levels.

This workshop's focus on mechanistic understanding is relevant because it pushes back against one-size-fits-all dosing and protocol design. For example, how luteal vs. follicular phase timing affects peptide efficacy, or how sex influences recovery from training stress, requires more detailed biological investigation than most current supplement or hormone literature provides. The emphasis on lifespan context also matters: a protocol effective at 35 may have different risk-benefit at 55, and these trajectories may differ by sex.

Caveats

  • Review article, not primary research: This is a summary of a workshop discussion, not novel experimental findings or data you can apply directly
  • No new data presented: The briefing cannot specify which sex differences were prioritized, which mechanisms emerged as most important, or what specific recommendations were made
  • Agenda-setting, not implementation: The value is in highlighting research gaps; solutions and validated protocols would come later
  • Breadth over depth: Covering "tissues and ages" across sexes suggests the workshop mapped territory rather than solved specific questions